BeOne Medicines Ltd. (ONC) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Beone Medicines Ltd. Class A.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.678 Good day, everyone. Welcome to Beijing's Q1 2025 earnings 00:00:05.678 -- 00:00:07.480 call webcast. 00:00:07.480 -- 00:00:12.786 All lines have been placed on mute to prevent any background noise. 00:00:12.786 -- 00:00:17.952 After the speaker's remarks, there will be a question and answer session. 00:00:17.952 -- 00:00:22.655 At this time, I would like to turn the call over to the company. 00:00:23.679 -- 00:00:25.941 Hello and welcome. Thanks for joining us today. 00:00:25.941 -- 00:00:29.258 I'm Dan Maller, head of investor relations at Beijing. 00:00:29.258 -- 00:00:33.751 Before we begin, please note that you can find additional materials including a replay 00:00:33.751 -- 00:00:36.995 of today's webcast and presentation 00:00:41.459 -- 00:00:45.244 I would like to remind all participants that during this call, we may make forward-looking 00:00:45.244 -- 00:00:49.531 statements regarding, among other things, the company's future prospects and business 00:00:49.531 -- 00:00:54.638 strategy. Actual results may differ materially from those indicated in the forward-looking 00:00:54.638 -- 00:00:59.565 statements as a result of various factors, including those risks discussed in our most 00:00:59.565 -- 00:01:03.090 recent periodic report filed with the SEC. 00:01:03.090 -- 00:01:06.875 Please also carefully review the forward-looking statements displayed on the slide deck 00:01:06.875 -- 00:01:09.573 that accompanies this presentation. 00:01:09.573 -- 00:01:14.039 Reconciliations between GAAP and non-GAAP financial measures discussed on this call are 00:01:14.039 -- 00:01:19.047 provided in the appendix to our presentation, which is posted to our investor relations 00:01:19.047 -- 00:01:21.951 website, along with our earnings rel...